Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 858 Records) |
Query Trace: JAK2[original query] |
---|
The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease's phenotype. Frontiers in oncology 2023 9 13 1224590. Patryk Sobieralski, Bartosz Was?g, Aleksandra Leszczy?ska, Monika ?uk, Maria Bieniaszews |
Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk. Diabetes care 2023 9 . Deirdre K Tobias, Alisa K Manning, Jennifer Wessel, Sridharan Raghavan, Kenneth E Westerman, Alexander G Bick, Daniel Dicorpo, Eric A Whitsel, Jason Collins, Adolfo Correa, L Adrienne Cupples, Josée Dupuis, Mark O Goodarzi, Xiuqing Guo, Barbara Howard, Leslie A Lange, Simin Liu, Laura M Raffield, Alex P Reiner, Stephen S Rich, Kent D Taylor, Lesley Tinker, James G Wilson, Peitao Wu, April P Carson, Ramachandran S Vasan, Myriam Fornage, Bruce M Psaty, Charles Kooperberg, Jerome I Rotter, James Meigs, JoAnn E Manson, |
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 2023 9 13 (1): 149. Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M Patna |
Genetic evidence supporting a causal role of Janus kinase 2 in prostate cancer: a Mendelian randomization study. The aging male : the official journal of the International Society for the Study of the Aging Male 2023 9 26 (1): 2257300. Yujia Xi, Rui Wen, Ran Zhang, Qirui Dong, Sijia Hou, Shengxiao Zha |
Leveraging Genomic and Bioinformatic Analysis to Enhance Drug Repositioning for Dermatomyositis. Bioengineering (Basel, Switzerland) 2023 8 10 (8): . Lalu Muhammad Irham, Wirawan Adikusuma, Anita Silas La'ah, Rockie Chong, Abdi Wira Septama, Marissa Angeli |
The Clinical Impact of JAK2V617F allele burden in Philadelphia-negative Myeloproliferative Neoplasms. Turkish journal of haematology : official journal of Turkish Society of Haematology 2023 8 . ?pek Yönal-Hindilerden, Ezgi ?ahin, Fehmi Hindilerden, Aynur Da?lar-Aday, Meliha Nalça |
Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing. Cancers 2023 8 15 (15): . Marta Garrote, Mónica López-Guerra, Eduardo Arellano-Rodrigo, María Rozman, Sara Carbonell, Francesca Guijarro, Marta Santaliestra, Ana Triguero, Dolors Colomer, Francisco Cervantes, Alberto Álvarez-Larr |
Expression properties, structural features and functional analysis of CALR E381A in MPN patients. American journal of translational research 2023 8 15 (7): 4718-4726. Kaihong Xu, Qunfang Ge, Yanli Zhang, Guifang Ouyang, Xiao Y |
Atypical CML: diagnosis and treatment. Hematology. American Society of Hematology. Education Program 2023 12 2023 (1): 476-482. Massimo Brecc |
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia 2023 12 . Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, Juliette Soret-Dulphy, Nabih Maslah, Lin-Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Valérie Ugo, Damien Luque Paz, Lydia Roy, Wayne-Corentin Lambert, Jean-Christophe Ianotto, Eric Lippert, Stéphane Giraudier, Bruno Cassinat, Jean-Jacques Kiladjian, Lina Benaji |
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient. Cancer gene therapy 2023 12 . Shubing Zhang, Jinhua Yan, Lan He, Zhiping Jiang, Hao Jia |
[Etiological analysis of a patient with multiple primary malignant neoplasms]. Zhonghua yi xue za zhi 2023 12 103 (47): 3848-3851. P J Shi, Y B Li, H P Xi |
JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms. Colombia medica (Cali, Colombia) 2023 12 54 (3): e2035353. Ana Isabel Giraldo-Rincón, Sara Naranjo Molina, Natalia Gomez-Lopera, Daniel Aguirre Acevedo, Andrea Ucroz Benavidez, Kenny Gálvez Cárdenas, Francisco Cuellar Ambrosí, Jose Domingo Torres, Sigifredo Ospina, Katherine Palacio, Lina Gaviria Jaramillo, Carlos Mario Muñeton, Gonzalo Vasquez Palac |
JAK2V617F Mutation and Associated Chromosomal Alterations in Primary and Secondary Myelofibrosis and Post-HCT Outcomes. Blood advances 2023 11 . Maryam Rafati, Derek Brown, Weiyin Zhou, Kristine M Jones, Wen Luo, Andrew St Martin, Youjin Wang, Meilun He, Stephen R Spellman, Tao Wang, H Joachim Deeg, Vikas Gupta, Stephanie J Lee, Yung-Tsi Bolon, Stephen J Chanock, Mitchell J Machiela, Wael Saber, Shahinaz M Gadal |
Detection of the JAK2 V617F Mutation in Urinary Cell-free DNA in Patients with Myeloproliferative Neoplasms. Internal medicine (Tokyo, Japan) 2023 11 . Hiroki Hosoi, Yoshikazu Hori, Katsuhiro Fukutsuka, Mitsuo Osuga, Yasuhiro Koh, Toshiki Mushino, Nobuyoshi Hanaoka, Nobuyuki Yamamoto, Hitoshi Ohno, Takashi Sono |
Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts. Journal of molecular medicine (Berlin, Germany) 2023 11 . Liuchao Zhang, Yuanyuan Wang, Liuying Wang, Meng Wang, Shuang Li, Jia He, Jianxin Ji, Kang Li, Lei C |
Molecular landscape of the JAK2 gene in chronic myeloproliferative neoplasm patients from the state of Amazonas, Brazil. Biomedical reports 2023 11 19 (6): 98. Dania G Torres, Emanuela V Barbosa Alves, Miliane Araújo de Sousa, Wanessa H Laranjeira, Jhemerson Paes, Erycka Alves, Deborah Canté, Allyson G Costa, Adriana Malheiro, Rosângela Abreu, Leny Nascimento, Nelson A Fraiji, George A V Silva, Lucivana P de Souza Mourão, Andréa M Tarra |
Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL-Negative Myeloproliferative Neoplasms. Hamostaseologie 2023 10 . Kai Wille, Eva Deventer, Parvis Sadjadian, Tatjana Becker, Vera Kolatzki, Karlo Hünerbein, Raphael Meixner, Marina Jiménez-Muñoz, Christiane Fuchs, Martin Griesshamm |
Associations of A20, CYLD, Cezanne and JAK2 Genes and Immunophenotype with Psoriasis Susceptibility. Medicina (Kaunas, Lithuania) 2023 10 59 (10): . Nguyen Hoang Giang, Nguyen Thi Kim Lien, Do Thi Trang, Pham Thi Huong, Nguyen Huy Hoang, Nguyen Thi Xu |
Noncoding RNA Profile in Reovirus Treated KRAS-Mutated Colorectal Cancer Patients. Diseases (Basel, Switzerland) 2023 10 11 (4): . Rafael Saperstein, Sanjay Goel, Radhashree Mait |
Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center Experience. Molecular diagnosis & therapy 2024 4 . Youngeun Lee, Soo Hyun Seo, Jinho Kim, Sang-A Kim, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang, Kyoung Un Park, Sang Mee Hwa |
Two Novel Genetic Variants Involved in the Oxygen Sensing Pathway in JAK2-unmutated Erythrocytosis. Biochemical genetics 2024 4 . Qiang Ma, Ronghua Hu, Wuhan Hui, Hong Zhao, Dongmei Zou, Yan Liu, Wanling S |
In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and heart failure: Insights from the National Readmissions Database. International journal of cardiology. Heart & vasculature 2024 1 49 101304. Orly Leiva, Jose Alvarez-Cardona, Joan How, Andrew Brunner, Gabriela Hob |
Abdominal venous thromboses: detection of the JAK2 p.V617F mutation by next-generation ultradeep sequencing-A prevalence study of patients in Mecklenburg-West Pomerania (2017-2021). Frontiers in medicine 2024 1 10 1344769. Larissa Henze, Luise Grunwald, Sabine Felser, Maria Witte, Christina Grosse-Thie, Catrin Roolf, Hugo Murua Escobar, Christian Junghan |
Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology. Annals of hematology 2024 1 . Marta Garrote, Mónica López-Guerra, Juan Carlos García-Pagán, Eduardo Arellano-Rodrigo, Francisca Ferrer-Marín, Juan Carlos Hernández-Boluda, Beatriz Bellosillo, Meritxell Nomdedeu, Virginia Hernández-Gea, Ana Triguero, Francesca Guijarro, José Álamo, Anna Baiges, Fanny Turon, Dolors Colomer, Francisco Cervantes, Alberto Alvarez-Larr |
Idiopathic erythrocytosis: a germline disease? Clinical and experimental medicine 2024 1 24 (1): 11. E M Elli, M Mauri, D D'Aliberti, I Crespiatico, D Fontana, S Redaelli, S Pelucchi, S Spinelli, B Manghisi, F Cavalca, A Aroldi, A Ripamonti, S Ferrari, S Palamini, F Mottadelli, L Massimino, D Ramazzotti, G Cazzaniga, A Piperno, C Gambacorti-Passerini, R Piaz |
One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood cancer journal 2024 1 14 (1): 11. Naseema Gangat, Omer Karrar, Aref Al-Kali, Kebede H Begna, Michelle A Elliott, Alexandra P Wolanskyj-Spinner, Animesh Pardanani, Curtis A Hanson, Rhett P Ketterling, Ayalew Teffe |
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 2024 1 14 (1): 10. Giuseppe G Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro M Vannucchi, Paola Guglielmel |
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk. Blood cancer journal 2024 1 14 (1): 6. Ashwin Kishtagari, M A Wasay Khan, Yajing Li, Caitlyn Vlasschaert, Naimisha Marneni, Alexander J Silver, Kelly von Beck, Travis Spaulding, Shannon Stockton, Christina Snider, Andrew Sochacki, Dixon Dorand, Taralynn M Mack, P Brent Ferrell, Yaomin Xu, Cosmin A Bejan, Michael R Savona, Alexander G Bi |
Insights into the role of JAK2-I724T variant in myeloproliferative neoplasms from a unique cohort of New Zealand patients. Hematology (Amsterdam, Netherlands) 2024 1 29 (1): 2297597. Christopher Puli'uvea, Tracey Immanuel, Taryn N Green, Peter Tsai, Peter R Shepherd, Maggie L Kalev-Zylins |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: